Expression of SRPK1 in gliomas and its role in glioma cell lines viability
- 177 Downloads
Among factors regulating the splicing of major importance is serine/arginine protein kinase 1 (SRPK1) that phosphorylates SR splicing factors. SRPK1 is expressed in the mammalian central nervous system in a region- and neuron-specific manner. Based on previous observations that glial cells are practically devoid of SRPK1 and reports showing aberrant expression of SRPK1 in numerous tumors, but with conflicting roles, this study aims to investigate the expression of SRPK1 in glioma and its influence on tumor cell biological features. As shown by immunohistochemical analysis, malignant glioma cells express SRPK1 in glioblastomas with significant association between SRPK1 expression and patients’ survival. SRPK1 expression was also significantly upregulated at the messenger RNA (mRNA) and protein level in glioma cell lines. Small interfering RNA-mediated downregulation of SRPK1 had little effect on cell viability, while it slightly enhanced the sensitivity of cells to killing by cisplatin. These results support the idea that at least in vitro, the effect of SRPK1 knockdown on the viability of glioma cell lines is rather limited, while the in vivo effects could be attributed to the modulation of angiogenesis by SRPK1.
KeywordsSRPK1 Gliomas Cell viabilty Chemotherapeutic agents Cisplatin 5-FU
This work was co-financed by the European Union and the Greek State, Ministry of Education and Religious Affairs/General Secretariat for Research and Technology, as well as by Josef and Esther Gani Foundation (Ioannina, Greece).
Compliance with ethical standards
The study was approved by the Review Board of the Neurosurgical Institute of Ioannina.
Conflicts of interest
- 22.Chang Y, Wu Q, Tian T, Li L, Guo X, Feng Z, et al. The influence of SRPK1 on glioma apoptosis, metastasis, and angiogenesis through the PI3K/Akt signaling pathway under normoxia. Tumour Biol. 2015.Google Scholar
- 25.Schenk PW, Boersma AW, Brandsma JA, den Dulk H, Burger H, Stoter G, et al. SKY1 is involved in cisplatin-induced cell kill in Saccharomyces cerevisiae and inactivation of its human homologue, SRPK1, induces cisplatin resistance in a human ovarian carcinoma cell line. Cancer Res. 2001;61:6982–6.PubMedGoogle Scholar